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Abstract 
    The hypothalamic/pituitary/gonadal (HPG)axis is central to the mammalian reproductive system . Pulsatile release 
of GnRH from neurons in the hypothalamus stimulates the secretion of LH and FSH from gonadotropes in the anterior 
pituitary. It has long been recognized that reproductive function is closely associated with energy balance, and 
metabolic dysregulation is linked with reproductive abnormalities (Lu et al.,2008). Compare the differences in levels 
of adiponectin, FSH, LH, testosterone and estradiol between the diabetic patients and control group and in diabetic 
patients according to the durations of disease for both males and females groups  .Also study the relationship between 
adiponectin and hormones for both gender and for both diabetic groups and control also in diabetic patients according 
to the durations of disease. About five milliliters of venous blood were collected from each subject in the study. The 
blood was separated by centrifugation at (3000 rpm) for 15 min. The sera were stored frozen at (-20 ºC) until assayed. 
This study was conducted between November 2010- November 2012 and, it was carried out at the diabetic Centre / 
Merjan Teaching Hospital in Babel Province, by taking 120 diabetic patients non- insulin dependent diabetes mellitus 
(NIDDM) (60 male  and 60 female)with disease durations(0-5),(>5-10 )and (>10 )years ,and with age average (35-65 
year), most of them were on oral hypoglycemic drugs, and the study included 40 people apparently healthy that 
included  20 male and 20 female with age average (35-65 year) ,as control matched with disease groups. The statistical 
analysis of this study showed that patients with Type 2 diabetes of both males and females had significantly lower in 
adiponectin levels than control group (P<0.05),but this level of adiponectin significantly higher in females than males 
for both diabetic groups and control (p<0.05)  ,while the levels of FSH and LH had significantly higher in diabetes 
group than control (p<0.05) ,also significantly higher  in females than males for both diabetic groups and control (P< 
0.05). The result of hormonal analysis show there were no significant differences in estradiol and testosterone between 
diabetic groups and control (p > 0.05). According to the durations of disease, the results show significant elevation in 
adiponectin level  in third duration of disease for both males and females groups as compared with first and second 
duration (P <0.004), while the levels of FSH, LH ,estradiol and testosterone show no significant differences among 
duration(P>0.05). According to the gender ,levels of adiponectin ,FSH, LH, and estradiol were significantly higher in 
females than males(P<0.05) , whereas levels of testosterone was significantly higher in males than females (P<0.05) . 
Correlation analysis showed an inverse correlation between adiponectin and FSH in female diabetic patients. Also an 
inverse correlation between adiponectin and estradiol was found in females of control group, while the correlation of 
LH and testosterone with adiponectin appears no significant correlation for both groups and for both males and females 
. According to the durations of disease, in first duration (0-5year)the study revealed positive correlation between 
adiponectin and FSH in male diabetic patients . In third duration (>10 year) an inverse correlation between adiponectin 
and FSH in female diabetic patients. The result also appears no significant correlation among adiponectin and LH, 
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estradiol and testosterone in both gender among duration . The results of the present study indicate that the patients 
with Type 2 diabetes of both males and females had significantly lower in adiponectin levels than control group . levels 
of adiponectin significantly higher in females than males for both diabetic groups and control. Adiponectin levels 
significantly increased with duration of disease also with age.  Levels of FSH and LH had significantly higher in 
diabetic patients than control also significantly higher in females than males for both groups . Correlation analysis 
showed inverse correlation between adiponectin and both FSH and estradiol in female diabetic patients also inverse 
correlation between adiponectin and both FSH and estradiol in third duration of female diabetic patients. 
 
1. Introduction 
      Adiponectin was first identified in 1995, circulates at relatively high concentration of 2 to 30 µg/ml in blood, 
accounting for up to 0.01% of total plasma protein in humans (Daimon et al.,2003;Shimada et al., 2004; Kadowaki et 
al.,2006 ;  Heidemann et al.,2008).  Adiponectin is lower in men than women, possibly as a result of suppression by 
androgens .Moreover, women have higher proportions of high molecular weight adiponectin than men (Gavrila et 
al.,2003 ; Snijder et al.,2006). Adiponectin exists in awide range of multimer complexes in plasma and 
combines via its collagen domain to create 3 major oligomeric forms: a low–molecular weight (LMW) 
trimer ,a middle - molecular weight(MMW)  hexamer ,and high-molecular weight(HMW) 12-18-mer adiponectin. 
Several observations support the hypothesis that HMW adiponectin is the more active form of the protein 
and has a more relevant role in insulin sensitivity and in protecting against diabetes ( Shimada et al.,2004; 
Kadowaki, et al.,2006 ; Heidemann et al.,2008). Testosterone (T) regulates many important physiologic processes, 
including muscle and fat metabolism, sexual development and function, erythropoiesis, and bone metabolism . Both 
T replacement therapy for hypogonadism and supraphysiologic administration of T are associated with increases in 
lean body mass, decreases in fat mass, and increases in muscle strength .T administration reduces overall fat mass  
and has been reported to decrease central adipose stores. . In mice, castration increased adiponectin levels and insulin 
sensitivity, effects neutralized by the coadministration of T, whereas ovariectomy had no effect on female mice , 
implying a role for T in adiponectin regulation in male mice. Together, these studies suggest that T might negatively 
regulate adiponectin production or serum half-life (Page et al.,2005 ;  Hugo et al.,2008).  In study of Tsujimura  et 
al.,(2009) refer to inversely relation between adiponectin levels and testosterone in rodents and humans.   Insulin is a 
negative regulator of liver secretion of sex hormone binding globulin(SHBG) . The concept has emerged that SHBG 
could be an interesting marker of insulin sensitivity in humans , and SHBG level has therefore been included as such 
among the biochemical markers for the risk of developing type 2 diabetes or cardiovascular diseases(Ducluzeau et 
al., 2003).   An inhibitory effect of insulin on SHBG secretion also has been reported by Bonnet et al.,(2009), 
suggesting that increased hyperinsulinemia could decrease SHBG concentration. Arecent study showed that 
monosaccharide , including glucose or fructose, regulate human SHBG gene expression .The reduction of SHBG 
secretion in response to increased concentrations of glucose may provide amechanism for the link between low-
plasma levels of SHBG and insulin resistance. There is a specific receptor for adiponectin in the liver, suggesting the 
potential implication of adiponectin in the regulation of the secretion of SHBG. 
 
Materiales and Method 
     About five milliliters of venous blood were collected from each subject in the study. The blood was separated by 
centrifugation at (3000 rpm) for 15 min. The sera were stored frozen at (-20 ºC) until assayed. 
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To determine the serum adiponectin, FSH, LH, estradiol and  testosterone the quantitative sandwich enzyme 
immunoassay technique were used. Moreover, the blood samples were taken in the morning exactly between 08:00 
and 10:00 h, minimizing the effect of diurnal variation (Tenhola et al.,2010). 
Adiponectin / Principle of assay  A monoclonal antibody specific for the adiponectin globular domain has been pre-
coated onto amicroplate. Standards and sample are pipette into the wells and any adiponectin present is bound by the 
immobilized antibody. After washing away any unbound substances, an enzyme-linked monoclonal antibody 
specific for the adiponectin globular domain is added to the wells. Following awash to remove any unbound 
antibody-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of 
adiponectin bound in the initial step. The color development is stopped and the intensity of the color is measured (R 
& D systems, Inc., Minneapolis, MN, USA) . 
 
Statistical  Analysis: 
      Analysis were performed using the Statistical Package for Social Sciences (SPSS version 18.0). Hormonal data 
were analyzed with durations of disease and with age using Factorial experiment with completely randomized design 
with three factors ,while analyzed between groups using Factorial experiment with completely randomized design 
with two factors . Data were represented as mean ± SE. Bivaraite correlations were performed using the Pearson 
correlation coefficient .P value (P<0.05) was considered statistically significant . 
 
Results: 
       The results of present study show there were significant differences in adiponectin level and some hormones 
levels between the diabetic groups and control.The mean adiponectin concentration differ significantly between two 
groups. Patients with Type 2 diabetes of both male and female had significantly lower levels of adiponectin 
concentration than control group ((3.84 ± 0.17) vs. (4.15 ± 0.3) and (5.81 ± 0 .3) vs.( 7.3 ± 0.17) (µg/ml)) (P<0.05)  
,while the levels of FSH and LH had significantly higher in diabetes group than control(p<0.05). Also the result of 
hormonal analysis show  there were no significant differences in estradiol and testosterone levels between diabetic 
patients and control (p > 0.05) as shown in Table(1). Levels of adiponectin and hormones according to gender had 
significantly differences in diabetes mellitus .Serum adiponectin concentration was significantly higher in females than 
males for both control and diabetic groups ((5.81 ± 0.17) vs. (3.84 ± 0.17) (µg/ml)) and  (7.3 ± 0.3) vs. (4.15 ± 0.3) 
(µg/ml)) (p<0.05).The levels of FSH, LH and estradiol were significantly higher in females than males for both 
diabetic groups and control (P< 0.05), whereas the testosterone concentration was significantly higher in males than 
females for both groups ((8.36 ± 0.07) vs. (0.68 ± 0.07) (ng/ml)) and ((7.58 ± 0.06) vs. (1.36 ± 0.06) (ng/ml)) 
respectively (P<0.05) as shown in Table(1). 
 
Discussion 
     The result of present study show that the patients with Type 2 diabetes of whether male or female had significantly 
lower in adiponectin concentration than control group and the levels of adiponectin was higher in female than male for 
both groups (Table 1), this may be due to a number of factors, one of them was the diabetic patients had decreased high 
molecular weight (HMW) -to- total adiponectin ratio, and HMW adiponectin correlated better with glucose tolerance 
than total adiponectin also the HMW was acted the active form of this protein . Women have more HMW adiponectin 
than men, which may partly explain the differences that we have found between men and women (Snijder et al.,2006). 
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Also decreased in adiponectin levels in diabetic patients may due to elevated plasma insulin in diabetic subjects in 
onset of diabetes and the insulin was down-regulated adiponectin mRNA expression ,and it has been found that the 
hyperinsulinemia associated with higher levels of adiponectin in Type 1 DM(Hotta et al.,2000 ; Huerta,2006; Habeeb 
et al.,2012 ). Testosterone(T) decrease adiponectin level by sequestering ARA70, acoactivator common to both the 
androgen receptor (AR) and peroxisome proliferator–activated receptor gamma 1 (PPARg1,2). The AR, and ARA70 
are all expressed in human adipocytes, and ARA70 is upregulated during adipocyte differentiation, a PPARg-mediated 
process. In this model, interaction of the AR with T might compete with PPARg for ARA70, resulting in reduced 
expression of PPARg-regulated genes such as adiponectin (Page et al.,2005). Mankowska et al.,(2008) indicate to 
human plasma adiponectin concentration is associated with sex and is significantly higher in weman than in men. This 
sexual dimorphism develop during pubertal development in relation to serum androgen. The result of this study agree 
with the study of Bai et al.,(2011) that found the patients with Type 2 diabetes have lower adiponectin serum 
concentration than healthy individuals. In diabetic patients and according to the duration of disease the results show 
significant elevation in adiponectin levels in third duration of disease for both males and females groups as compared 
with first and second duration(Table 2) ,this differences belong to that adiponectin is lowest in the presence of impaired 
glucose regulation and early diabetes, whereas long diabetes duration is associated with a significant increase in 
circulating adiponectin, changes in insulin concentration with increasing duration of diabetes could be one mechanism 
by which serum adiponectin is influenced by diabetes duration (Looker et al.,2004 ; Eynatten et al.,2009).  Also study 
show the patients with Type 2 diabetes had revealed defect in hypothalamic than pituitary axis .Levels of FSH and LH 
significantly higher in diabetes group than control (P<0.05), while the levels of estradiol and testosterone show no 
significant differences between groups (Table 4),this is because that insulin is known to facilitate 
gonadotropin-releasing hormone (GnRH) secretion by hypothalamic neurons(Dhindsa et al.,2011). In study by  
Ermetici et al.,(2009) indicated to the insulin-like factor 3 (INSL3), a member of the insulin–relaxin superfamily of 
peptide hormones, has been used as a specific marker of Leydig cell differentiation and function, since it appears more 
sensitive than testosterone itself in evaluating function . The global impairment of Leydig cell function in T2DM is 
confirmed by the finding of reduced circulating levels of INSL3, a novel peptide hormone mainly derived from Leydig 
cells, which have been indicated as an absolute measure of either quality or number of the Leydig cells, independently 
from gonadotropin stimulation . The higher LH levels in diabetic patients than in controls might suggest that when few 
or poor-quality Leydig cells are present, more LH is required to achieve normal circulating testosterone levels. Since 
the presence of the INSL3 receptor has been demonstrated at pituitary level, a possible negative feedback of INSL3 has 
also been hypothesized. Also may be because that leydig cells and follicle cells become resistant to gonadotropin 
hormone as aresult higher levels of FSH and LH with low normal range of estradiol and testosterone in diabetic 
patients. The result show no significant differences in testosterone concentration between control and diabetic patients 
whereas the average testosterone concentration was significantly higher in males for both groups than in females and in 
diabetic pateints among duration(Table 1 and 2),this result agreement with study of Bia et al.,(2011) that found there 
were no significant differences in mean testosterone concentration between the diabetic patients Type 2 and control 
group , also found that in both patients and control group average testosterone concentration was higher in males than 
females. These result also show no significant differences between the diabetic patients Type 2 and control group in 
estradiol concentration which supported by study of AL-Saadi,(2005) that found no significant differences in the levels 
of estradiol hormone between women with Type 2 diabetes and healthy women in postmenopausal age.  According to 
the gender ,levels of FSH ,LH and estradiol were significant higher in females than males for both control and diabetic 
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group and in diabetic group among duration of disease(Table 1 and 2) .Bonnet et al., (2009) refer that sex 
hormone-binding globulin levels(SHBG) was higher in females than males for both control and diabetic groups which 
made the percentage of free estradiol and the negative feedback mechanism in female was highly than in males which 
may cause the levels of FSH and LH became highly in females than males.  In diabetic patients according to the 
duration of disease, levels of FSH, LH ,estradiol and testosterone show no significant differences among duration 
(Table 2) .Higher levels of FSH, LH ,estradiol and testosterone in first duration in males and in second duration in 
females causes lower levels from adiponectin in this duration but this changes not reach to the significant value. 
Changes in insulin concentration with increasing duration of diabetes and because the insulin is known to facilitate 
gonadotropin-releasing hormone (GnRH) secretion by hypothalamic neurons (Looker et al.,2004 ; Dhindsa et 
al.,2011) . An inverse correlation between adiponectin and FSH in female diabetic patients(Table 3) also in third 
duration of female diabetic patients(Table 4) ,while the correlation of LH with adiponectin appears no significant 
correlation for both groups and for both males and females (Table 3) and in diabetic patients among duration(Table 4) 
,this is because that adiponectin decreases basal and GnRH-stimulated LH secretion via activation of AMPK. A 
decrease in cellular ATP activates AMPK that, in turn, inhibits energy-requiring processes and stimulates ATP 
production by increasing glucose uptake and fatty acid oxidation .Trafficking and fusion of secretory vesicles is ATP 
dependent, so may be directly inhibited by AMPK. Alternatively, the calcium increases essential for stimulating 
secretion may be blocked (Lu et al., 2008).  Adiponectin is present in follicular fluid and induces cyclooxygenase 
2,prostaglandin E synthase, vascular endothelial growth factor, and steroidogenic acute regulatory protein mRNAs(Lu 
et al., 2008),this may be result that adiponectin affected in FSH levels more than LH, which may be explain this inverse 
correlation between adiponectin and FSH also with LH level but in this study not reach to significant levels. An inverse 
correlation between adiponectin and estradiol was found in females of control group(Table 3), because the estrogen 
may be involved in adipose tissue disposition and regulation preadipocyte proliferating and differentiation ,thus, could 
reduce adiponectin (Tworoger et al.,2007). 
       This result supported by result of (Gavrila et al., 2003) that found adiponectin has been inversely associated 
with estrogen levels in healthy women. Despite the negative association between estradiol and adiponectin, it has been 
reported that women have higher adiponectin levels compared with men , suggesting that in addition to estrogens, other 
gender-dependent factors, such as body fat distribution or androgen may be of relevance.  
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Table(1): Differences  in levels of adiponectin and some hormones between Type 
 2diabetic patients and control and between gender. 
 
P value is significant ≤ 0 .05 level.    S.E :Standard error 
 According to the durations of disease, the results show significant elevation in adiponectin level  in third duration of 
disease for both males and females groups (4.28 ±0.31) and (7.6 ± 0.31) as compared with first and second duration 
(3.35 ± 0.31),(3.89 ± 0.31)and(5.38 ± 0.31) ,(4.44± 0.31) respectively (P <0.004), while the levels of FSH, LH 
,estradiol and testosterone show no significant differences among duration(P>0.05). According to the gender ,levels 
of adiponectin ,FSH, LH, and estradiol were significantly higher in females than males(P<0.05) , whereas levels of 
testosterone was significantly higher in males than females (P<0.05) as shown in Table (2). 
 
Table(2): Comparison of adiponectin levels and some hormones of Type 2diabetic patients among durations of 
disease and between gender              
P value is significant ≤ 0 .05 level.             S.E :Standard error 
P value 
of 
group 
P value 
of gender 
Diabetes groups  
(Means± S.E.) 
Control   
(Means± S.E.) 
Groups 
 
Indices Female Male Female Male 
0.04* 0.00* 5.81 ± 0.17 3.84 ± 0.17 7.3 ± 0.3 4.15 ± 0.3 Adiponectin(µg/ml) 
0.03* 0.008* 38.62 ± 4.79 28.01 ± 4.79 31.6 ± 0.3 8.78 ± 0.3 FSH(mIU/ml) 
0.04* 0.00* 18.23 ± 0.36 6.94 ± 0.36 12.53 ± 0.36 4.63 ± 0.36 LH( mIU /ml) 
0.85 0.05* 35.02 ± 4.59 21.07 ± 4.59 32.13 ± 4.95 21.53 ± 4.95 Estradiol(pg/ml) 
0.27 0.00* 1.36 ± 0.06 7.58 ± 0.06 0.68 ± 0.07 8.36 ± 0.07 Testosterone (ng/ml) 
0.27 0.00* 1.36 ± 0.06 7.58 ± 0.06 0.68 ± 0.07 8.36 ± 0.07 Testosterone (ng/ml) 
P value of 
duration  
P value 
of 
gender  
Diabetes groups       (Means± S.E.)    
Indices 
 
>10 >5-10 0-5  
Female Male  Female Male Female  Male  
0.004* 0.002* 7.6 ± 0.31 
4.28 ± 
0.31 
4.44 ± 
0.31 
3.89 ± 
0.31  
5.38 ± 
0.31 
3.35 ± 
0.31  
Adiponectin 
(µg/ml) 
0.055 0.008* 
38.39 ± 
0.34 
36.06 ± 
0.34 
41.31 ± 
0.34  
29.8 ± 
0.34 
36.18 ± 
0.34  
18.16 ± 
0.34 
FSH(mIU /ml) 
 
0.17 0.00* 
16.18 ± 
0.31 
6.72 ± 
0.31 
22.95 ± 
0.31 
5.56 ± 
0.31 
15.55 ± 
0.31 
8.52 ± 
0.31 
LH( mIU l/ml) 
0.97 0.02* 
32.38 ± 
4.17 
21.07 ± 
4.17 
38.71 ± 
4.17 
20.98 ± 
4.17 
33.98 ± 
4.17 
21.17 ± 
4.17 
Estradiol 
(pg/ml) 
0.22 0.00* 
1.51 ± 
0.09 
8.25 ± 
0.09 
1.00 ± 
0.09 
6.00 ± 
0.09 
1.58 ± 
0.09 
8.48 ± 
0.09 
Testosterone 
(ng/ml) 
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       Correlation analysis showed an inverse correlation between adiponectin and FSH in female diabetic patients (r= 
-0.35,P= 0.03).Also an inverse correlation between adiponectin and estradiol was found in females of control group, 
while the correlation of LH and testosterone with adiponectin appears no significant correlation for both groups and for 
both males and females as shown in Table (3) . 
 
Table(3): Correlation analysis between adiponectin and some hormones of Type 2diabetic patients and control. 
Correlation coefficient (r) 
*. Correlation is significant ≤ 0.05 level (2-tailed).  
 
   According to the durations of disease, the study revealed in male diabetic patients positive correlation between 
adiponectin and FSH in first duration was found(r= 0.78,P= 0.01 .In female diabetic patients an inverse correlation 
between adiponectin and FSH in third duration of female diabetic patients(r= -0.75,P= 0.01) and (r= -0.67,P= 0.04) 
respectively, The results appears no significant correlation between adiponectin with LH, estradiol and testosterone in 
both sex among duration as shown in Table (4) . 
 
  
Adiponectin(µg/ml) 
Diabetes groups  
Adiponectin(µg/ml) 
Control groups  
Groups 
 
  
Indices 
Female Male  Female Male 
P value r P value r P value r P value  r 
0.03 -0.35* 0.94 -0.01 0.24  -0.42 0.34 0.35 FSH( mIU /ml)  
0.34 -0.19 0.92 0.01 0.26 -0.41 0.5  0.25 LH( mIU /ml) 
0.47 -0.14 0.74 0.06 0.05 -0.25* 0.54 -0.67 Estradiol(pg/ml)  
0.37 0.17 0.88 -0.03 0.16 0.5 0.09 0.59 
Testosterone 
(ng/ml) 
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Table(4): The relationship between adiponectin and hormones of diabetic patients Type 2 according to the 
durations of disease 
Correlation coefficient (r)                  *. Correlation is significant ≤ 0.05 level (2-tailed). 
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